EVOLUTION OF CARDIOVASCULAR RISK WITH NORMAL AGING
正常衰老过程中心血管风险的演变
基本信息
- 批准号:7918134
- 负责人:
- 金额:$ 55.19万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2000
- 资助国家:美国
- 起止时间:2000-05-15 至 2012-08-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
DESCRIPTION (provided by applicant): The cardiovascular (C-V) system is a vital organ system most affected by the aging process. The natural history of C-V aging in terms of arterial and cardiac structure/function (C-V indices) is governed by a complex interplay between an intrinsic (biologic) aging effect and a burden of C-V risk factors beginning early in life. This renewal application focuses on the pathobiological traits associated with C-V aging in a community-based, black-white, middle-aged cohort having been followed over 30 years beginning in childhood. The specific aims are to 1) continue monitoring the progression of C-V indices with respect to chronological age, the burden of C-V risk factor variables and familial traits of C-V risk and longevity; 2) determine the relationship between changes in C-V indices and biological aging ascertained by chromosomal telomere dynamics; 3) examine the influence of birth weight on the burden of C-V risk factor variables since childhood and the rate of adverse changes in C-V indices. The ongoing study cohort followed during the previous grant period (Cohort I, n=1,200) and an additional cohort examined as children 10 years ago (Cohort II, n=1,200) are available to achieve these aims. In addition to telomere dynamics, birth weight, and subclinical C-V indices, data on selected key variables relevant to C-V aging, in particular risk variables of metabolic syndrome including inflammation and oxidative stress will be collected. Both cohorts will be examined for 1) C-V indices by carotid IMT, left ventricular structure and function, brachial artery compliance, and arterial pulse wave velocity; 2) C-V risk factor variables comprising obesity measures, blood pressure, lipoprotein variables, glucose, insulin, and parameters of oxidative stress; and 3) telomere length. In addition, data on birth weight, adiponectin, insulin like growth factor-I and binding proteins, homocysteine, fibrinogen, plasminogen activator inhibitor-I, C-reactive protein, interleukin-6, and intercellular adhesion molecule-1 will be obtained in Cohort I; telomere attrition rate from childhood to adulthood and familial traits of C-V risk and longevity in Cohort I1. The extensive serial database of the Bogalusa Heart Study provides unique and valuable resources. Findings from the proposed research will further the understanding of C-V aging and predisposing factors that influence aging in a bi-racial young to middle age population. Observations derived from this research will help develop effective preventive strategies to temper mediators that influence premature C-V morbidity and mortality.
描述(由申请人提供):心血管(C-V)系统是受衰老过程影响最大的重要器官系统。在动脉和心脏结构/功能(C-V指数)方面,C-V衰老的自然历史受固有(生物学)衰老效应的复杂相互作用与从生命早期开始的C-V风险因素负担之间的复杂相互作用。这种更新应用的重点是与C-V衰老相关的病理学特征,在童年开始的30年以上,遵循了30年的社区,黑白,中年队列。具体目的是1)继续监视C-V指数的进展,相对于年龄,C-V风险因素变量的负担以及C-V风险和寿命的家族性状的负担; 2)确定C-V指数变化与染色体端粒动力学确定的生物老化之间的关系; 3)检查出生体重自儿时以来C-V风险因素变量负担的影响以及C-V指数不良变化的率。正在进行的研究队列遵循上一个赠款期(队列I,n = 1,200)和10年前的儿童(同类II,n = 1,200)检查的其他队列可用于实现这些目标。除了端粒动力学,出生体重和亚临床C-V指数外,还将收集与C-V衰老相关的选定关键变量的数据,特别是代谢综合征的风险变量,包括炎症和氧化应激。将通过颈动脉IMT,左心室结构和功能,臂动脉依从性和动脉脉冲波速度检查两个队列的1)C-V指数。 2)C-V风险因素变量包括肥胖症测量,血压,脂蛋白变量,葡萄糖,胰岛素和氧化应激的参数; 3)端粒长度。 此外,在同胞I中将获得有关出生体重,脂联素,胰岛素(如生长因子I)和结合蛋白,同型半胱氨酸,纤维蛋白原,纤维蛋白原激活剂抑制剂,C反应蛋白,白介素6和细胞间粘附分子1的数据。从童年到成年期的端粒损耗率以及C-V风险和寿命I1的家族性质。 Bogalusa心脏研究的广泛序列数据库提供了独特而有价值的资源。拟议的研究的结果将进一步了解C-V衰老和易于影响的因素,这些因素会影响双种族年轻人至中年人口的衰老。 这项研究得出的观察结果将有助于制定有效的预防策略,以调节影响过早C-V发病率和死亡率的调解人。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

暂无数据
数据更新时间:2024-06-01
GERALD Sanders BER...的其他基金
Evolution of Cardiovascular Risk with Normal Aging
正常衰老过程中心血管风险的演变
- 批准号:84369388436938
- 财政年份:2012
- 资助金额:$ 55.19万$ 55.19万
- 项目类别:
Evolution of Cardiovascular Risk with Normal Aging
正常衰老过程中心血管风险的演变
- 批准号:87237118723711
- 财政年份:2012
- 资助金额:$ 55.19万$ 55.19万
- 项目类别:
Evolution of Cardiovascular Risk with Normal Aging
正常衰老过程中心血管风险的演变
- 批准号:85482138548213
- 财政年份:2012
- 资助金额:$ 55.19万$ 55.19万
- 项目类别:
Evaluation of Cardiovascular Health Among Residents
居民心血管健康状况评价
- 批准号:70440237044023
- 财政年份:2003
- 资助金额:$ 55.19万$ 55.19万
- 项目类别:
EVOLUTION OF CARDIOVASCULAR RISK WITH NORMAL AGING
正常衰老过程中心血管风险的演变
- 批准号:63722986372298
- 财政年份:2000
- 资助金额:$ 55.19万$ 55.19万
- 项目类别:
EVOLUTION OF CARDIOVASCULAR RISK WITH NORMAL AGING
正常衰老过程中心血管风险的演变
- 批准号:71195577119557
- 财政年份:2000
- 资助金额:$ 55.19万$ 55.19万
- 项目类别:
EVOLUTION OF CARDIOVASCULAR RISK WITH NORMAL AGING
正常衰老过程中心血管风险的演变
- 批准号:72885887288588
- 财政年份:2000
- 资助金额:$ 55.19万$ 55.19万
- 项目类别:
EVOLUTION OF CARDIOVASCULAR RISK WITH NORMAL AGING
正常衰老过程中心血管风险的演变
- 批准号:67927306792730
- 财政年份:2000
- 资助金额:$ 55.19万$ 55.19万
- 项目类别:
EVOLUTION OF CARDIOVASCULAR RISK WITH NORMAL AGING
正常衰老过程中心血管风险的演变
- 批准号:74894257489425
- 财政年份:2000
- 资助金额:$ 55.19万$ 55.19万
- 项目类别:
EVOLUTION OF CARDIOVASCULAR RISK WITH NORMAL AGING
正常衰老过程中心血管风险的演变
- 批准号:60537416053741
- 财政年份:2000
- 资助金额:$ 55.19万$ 55.19万
- 项目类别:
相似国自然基金
多氯联苯与机体交互作用对生物学年龄的影响及在衰老中的作用机制
- 批准号:82373667
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
恒星模型中氧元素丰度的变化对大样本F、G、K矮星年龄测定的影响
- 批准号:12303035
- 批准年份:2023
- 资助金额:30.00 万元
- 项目类别:青年科学基金项目
基于年龄和空间的非随机混合对性传播感染影响的建模与研究
- 批准号:12301629
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
母传抗体水平和疫苗初种年龄对儿童麻疹特异性抗体动态变化的影响
- 批准号:82304205
- 批准年份:2023
- 资助金额:20 万元
- 项目类别:青年科学基金项目
中国东部地区大气颗粒物的年龄分布特征及其影响因素的模拟研究
- 批准号:42305193
- 批准年份:2023
- 资助金额:30.00 万元
- 项目类别:青年科学基金项目
相似海外基金
The Influence of Lifetime Occupational Experience on Cognitive Trajectories Among Mexican Older Adults
终生职业经历对墨西哥老年人认知轨迹的影响
- 批准号:1074860610748606
- 财政年份:2024
- 资助金额:$ 55.19万$ 55.19万
- 项目类别:
The Proactive and Reactive Neuromechanics of Instability in Aging and Dementia with Lewy Bodies
衰老和路易体痴呆中不稳定的主动和反应神经力学
- 批准号:1074953910749539
- 财政年份:2024
- 资助金额:$ 55.19万$ 55.19万
- 项目类别:
Understanding the Mechanisms and Consequences of Basement Membrane Aging in Vivo
了解体内基底膜老化的机制和后果
- 批准号:1046501010465010
- 财政年份:2023
- 资助金额:$ 55.19万$ 55.19万
- 项目类别:
Safety and Tolerability of TASIS-Peanut (Targeted Allergen Specific Immunotherapy within the Skin) patch for the Treatment of Peanut Allergy
TASIS-花生(皮肤内靶向过敏原特异性免疫疗法)贴剂治疗花生过敏的安全性和耐受性
- 批准号:1055118410551184
- 财政年份:2023
- 资助金额:$ 55.19万$ 55.19万
- 项目类别:
Identifying and Addressing the Effects of Social Media Use on Young Adults' E-Cigarette Use: A Solutions-Oriented Approach
识别和解决社交媒体使用对年轻人电子烟使用的影响:面向解决方案的方法
- 批准号:1052509810525098
- 财政年份:2023
- 资助金额:$ 55.19万$ 55.19万
- 项目类别: